Effect of Aspergillus fumigatus and Candida albicans on pro-inflammatory response in cystic fibrosis epithelium  James A. Reihill, John E. Moore, J. Stuart.

Slides:



Advertisements
Similar presentations
Use of the insulin pump in treat cystic fibrosis related diabetes Dana S. Hardin, Julie Rice, Mark Rice, Randall Rosenblatt Journal of Cystic Fibrosis.
Advertisements

Ian D. Molyneux, Tanya Moon, A. Kevin Webb, Alyn H. Morice 
Azithromycin fails to reduce increased expression of neutrophil-related cytokines in primary-cultured epithelial cells from cystic fibrosis mice  Ximena.
Cystic Fibrosis Foundation and European Cystic Fibrosis Society Survey of cystic fibrosis mental health care delivery  J. Abbott, J.S. Elborn, A.M. Georgiopoulos,
Vitamin D receptor agonists inhibit pro-inflammatory cytokine production from the respiratory epithelium in cystic fibrosis  P. McNally, C. Coughlan,
Lael M. Yonker, Cristina Cigana, Bryan P. Hurley, Alessandra Bragonzi 
Population structure and characterization of viridans group streptococci (VGS) including Streptococcus pneumoniae isolated from adult patients with cystic.
Indicators of pulmonary exacerbation in cystic fibrosis: A Delphi survey of patients and health professionals  Fiona McCourt, Brenda O'Neill, Ian Logan,
The immediate effect of musculoskeletal physiotherapy techniques and massage on pain and ease of breathing in adults with cystic fibrosis  Annemarie Lee,
Development, validation, and implementation of a questionnaire assessing disease knowledge and understanding in adult cystic fibrosis patients  Karen.
Cystic fibrosis research in allied health and nursing professions
How does heart rate recovery after sub-maximal exercise correlate with maximal exercise testing in children with CF?  Sarah P. Cohen, David M. Orenstein 
Avani C. Modi, Crystal S. Lim, Nami Yu, David Geller, Mary H
Single high-dose oral vitamin D3 (stoss) therapy — A solution to vitamin D deficiency in children with cystic fibrosis?  Darren Shepherd, Yvonne Belessis,
Megan R. Nelson, Craig R. Adamski, Audrey Tluczek 
Successful treatment of cepacia syndrome
Urinary incontinence in 9���16��year olds with cystic fibrosis compared to other respiratory conditions and a normal group  W.J. Browne, C.J. Wood, M.
Measures of body habitus are associated with lung function in adults with cystic fibrosis: A population-based study  Doug L. Forrester, Alan J. Knox,
Development of selective media for the isolation of yeasts and filamentous fungi from the sputum of adult patients with cystic fibrosis (CF)  Yuriko Nagano,
Raphaël Chiron, Y. Yaël Grumbach, Nga V. T
Defining antimicrobial resistance in cystic fibrosis
Role of the dual interaction of fungal pathogens with pattern recognition receptors in the activation and modulation of host defence  M.G. Netea, J.W.M.
Cirrhosis and other liver disease in cystic fibrosis
Safety and efficacy of prolonged levofloxacin inhalation solution (APT-1026) treatment for cystic fibrosis and chronic Pseudomonas aeruginosa airway infection 
A pilot study on the safety and efficacy of a novel antioxidant rich formulation in patients with cystic fibrosis  Konstantinos A. Papas, Marci K. Sontag,
Bronchial epithelial cell lines and primary nasal epithelial cells from cystic fibrosis respond differently to cigarette smoke exposure  Mark Thomas Shaw.
Geneviève Héry-Arnaud, Sébastien Boutin, Leah Cuthbertson, Stuart J
Fiona K. Dunlevy, S. Lorraine Martin, Francine de Courcey, J
Expression of the inflammatory regulator A20 correlates with lung function in patients with cystic fibrosis  Catriona Kelly, Mark T. Williams, J. Stuart.
Controlled clinical trials in cystic fibrosis — are we doing better?
Anju Anand, Elizabeth Tullis, Anne Stephenson, Preyanka Abhyankar 
D. Stevens, P.J. Oades, N. Armstrong, C.A. Williams 
Claire J. Tipping, Rebecca L. Scholes, Narelle S. Cox 
Comparison of real time diagnostic chemistries to detect Pseudomonas aeruginosa in respiratory samples from cystic fibrosis patients  J.L. Fothergill,
Gerd Döring, Patrick Flume, Harry Heijerman, J. Stuart Elborn 
Implementation of European standards of care for cystic fibrosis ��� Control and treatment of infection  J.S. Elborn, M. Hodson, C. Bertram  Journal of.
The Journal of Cystic Fibrosis: Sunny perspectives
Interferon response of the cystic fibrosis bronchial epithelium to major and minor group rhinovirus infection  Aline Schögler, Andrea B. Stokes, Carmen.
Cytokines in nasal lavages and plasma and their correlation with clinical parameters in cystic fibrosis  Marthe S. Paats, Ingrid M. Bergen, Marleen Bakker,
A.H. Gifford  Journal of Cystic Fibrosis 
Treatment of resistant distal intestinal obstruction syndrome with a modified antegrade continence enema procedure  I.J. Clifton, A.M. Morton, N.S. Ambrose,
Osteoclast function, bone turnover and inflammatory cytokines during infective exacerbations of cystic fibrosis  Elizabeth F. Shead, Charles S. Haworth,
Cystic fibrosis related diabetes in an extremely young patient
Inhalation solutions — Which ones may be mixed
Antonia V. Bennett, Donald L. Patrick, James F. Lymp, Todd C
E. Tschiedel, H. Grasemann, F. Ratjen  Journal of Cystic Fibrosis 
Direct comparison of in vitro susceptibility of wildtype clinical Pseudomonas aeruginosa isolated from adult patients with cystic fibrosis (CF) to TOBI®
Roel P. Gazendam, MD, Annemarie van de Geer, MD, John L
Sally H. Pattison, Geraint B. Rogers, Martin Crockard, J
Anastasios Lekkas, Khin M. Gyi, Margaret E. Hodson 
Prevalence and risk factors for recovery of filamentous fungi in individuals with cystic fibrosis  Christopher R. Sudfeld, Elliott C. Dasenbrook, William.
Cytokine gene polymorphisms and severity of CF lung disease
Volume 143, Issue 6, (December 2010)
Gender differences in treatment adherence among youth with cystic fibrosis: Development of a new questionnaire  Joän M. Patterson, Melanie Wall, Jerica.
Segregation of children with CF diagnosed via newborn screening and acquisition of Pseudomonas aeruginosa  Karen O. McKay, Peter J. Cooper, Peter P. van.
Alina A. Ionescu, Lisette S. Nixon, Dennis J. Shale 
Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985–2005  F.A. Millar, N.J. Simmonds, M.E. Hodson  Journal.
Protease-dependent activation of epithelial cells by fungal allergens leads to morphologic changes and cytokine production  Henk F. Kauffman, PhD, J.F.Chris.
A. Sapet, A. C. Normand, M. Oudyi, N. Stremler- Le Bel, R. Piarroux, J
H. White, A.M. Morton, S.P. Conway, D.G. Peckham 
Reviewer Acknowledgment
D.F. Waterhouse, A.M. McLaughlin, C.G. Gallagher 
‘Peeling paint’ dermatitis as a presenting sign of cystic fibrosis
Lutz Goldbeck, Sven Zerrer, Tim G. Schmitz  Journal of Cystic Fibrosis 
Khin M. Gyi, Margaret E. Hodson, Magdi Y. Yacoub 
David Adeboyeku, Sandra Scott, Margaret E. Hodson 
Elisabeth P. Dellon, Margaret W. Leigh, James R. Yankaskas, Terry L
A safe protocol for rapid desensitization in patients with cystic fibrosis and antibiotic hypersensitivity  Henry J. Legere, Ross I. Palis, Tito Rodriguez.
Population pharmacokinetics of tobramycin administered thrice daily and once daily in children and adults with cystic fibrosis  D.J. Touw, A.J. Knox,
Safety assessment of inhaled xylitol in subjects with cystic fibrosis
Presentation transcript:

Effect of Aspergillus fumigatus and Candida albicans on pro-inflammatory response in cystic fibrosis epithelium  James A. Reihill, John E. Moore, J. Stuart Elborn, Madeleine Ennis  Journal of Cystic Fibrosis  Volume 10, Issue 6, Pages 401-406 (December 2011) DOI: 10.1016/j.jcf.2011.06.006 Copyright © 2011 Terms and Conditions

Fig. 1 Cytokine release from Candida albicans-treated HBE and CFBE. HBE (filled diamonds) and CFBE (filled squares) were treated with varying doses of Candida albicans whole cells as indicated for 24h then IL-6 (A) and IL-8 (B) levels determined by ELISA (n=5). Treatment of cells with cytomix (positive control) gave the following values HBE IL-6 1695±305pg/ml, IL-8 2013±117pg/ml CFBE: IL-6 3050±322pg/ml, IL-8 2297±236pg/ml (data not shown) (C). THP-1 cells were treated with an equal ratio (1:1) of Candida albicans whole cells (n=3) or Aspergillus fumigatus conidia (n=3) for 24h then IL-8 was assessed by ELISA. Treatment of THP-1 cells with cytomix gave the following: 1083±114.9pg/ml. *p<0.05 compared with basal. Journal of Cystic Fibrosis 2011 10, 401-406DOI: (10.1016/j.jcf.2011.06.006) Copyright © 2011 Terms and Conditions

Fig. 2 Cytokine release from Aspergillus fumigatus-treated HBE and CFBE. HBE (filled diamonds) and CFBE (filled squares) were treated with varying doses of Aspergillus fumigatus conidia as indicated for 24h then IL-6 (A) and IL-8 (B) levels determined by ELISA. Data shown in A and B is representative of at least 6 independent experiments. Treatment of cells with cytomix resulted in the following cytokine levels HBE IL-6 1795±236pg/ml, IL-8 2022±116pg/ml CFBE: IL-6 2983±335pg/ml, IL-8 2320±310pg/ml. (C) HBE or CFBE were treated with varying doses of Aspergillus fumigatus conidia then LDH levels were measured (n=3). A 1% v/v LDH solution in culture media served as a positive control. *p<0.05 **p<0.01 compared with basal. Journal of Cystic Fibrosis 2011 10, 401-406DOI: (10.1016/j.jcf.2011.06.006) Copyright © 2011 Terms and Conditions